| Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors A Gurney, F Axelrod, CJ Bond, J Cain, C Chartier, L Donigan, M Fischer, ... Proceedings of the National Academy of Sciences 109 (29), 11717-11722, 2012 | 638 | 2012 |
| Variable domain library and uses CJ Bond, S Sidhu US Patent 7,785,903, 2010 | 295 | 2010 |
| Synthetic antibody phage libraries C Bond US Patent App. 10/759,731, 2005 | 293 | 2005 |
| Structural evidence for a germline-encoded T cell receptor–major histocompatibility complex interaction'codon' D Feng, CJ Bond, LK Ely, J Maynard, KC Garcia Nature immunology 8 (9), 975-983, 2007 | 250 | 2007 |
| Targeting Notch signaling with a Notch2/Notch3 antagonist (tarextumab) inhibits tumor growth and decreases tumor-initiating cell frequency WC Yen, MM Fischer, F Axelrod, C Bond, J Cain, B Cancilla, WR Henner, ... Clinical cancer research 21 (9), 2084-2095, 2015 | 249 | 2015 |
| Comprehensive analysis of the factors contributing to the stability and solubility of autonomous human VH domains PA Barthelemy, H Raab, BA Appleton, CJ Bond, P Wu, C Wiesmann, ... Journal of Biological Chemistry 283 (6), 3639-3654, 2008 | 240 | 2008 |
| Contributions of CDR3 to VHH domain stability and the design of monobody scaffolds for naive antibody libraries CJ Bond, JC Marsters Jr, SS Sidhu Journal of molecular biology 332 (3), 643-655, 2003 | 138 | 2003 |
| A structure-based database of antibody variable domain diversity CJ Bond, C Wiesmann, JC Marsters Jr, SS Sidhu Journal of molecular biology 348 (3), 699-709, 2005 | 74 | 2005 |
| Six, Seven or Eight Coordinate FeII, CoII or NiII Complexes of Amide‐Appended Tetraazamacrocycles for ParaCEST Thermometry AO Olatunde, CJ Bond, SJ Dorazio, JM Cox, JB Benedict, MD Daddario, ... Chemistry–A European Journal 21 (50), 18290-18300, 2015 | 52 | 2015 |
| Phage‐display as a tool for quantifying protein stability determinants JD Kotz, CJ Bond, AG Cochran European journal of biochemistry 271 (9), 1623-1629, 2004 | 40 | 2004 |
| VEGF/DLL4 binding agents and uses thereof AL Gurney, AK Sato, CJ Bond US Patent 8,858,941, 2014 | 34 | 2014 |
| Exploring inner-sphere water interactions of Fe (II) and Co (II) complexes of 12-membered macrocycles to develop CEST MRI probes CJ Bond, GE Sokolow, MR Crawley, PJ Burns, JM Cox, R Mayilmurugan, ... Inorganic chemistry 58 (13), 8710-8719, 2019 | 30 | 2019 |
| Gadolinium-based contrast agents L Helm, JR Morrow, CJ Bond, F Carniato, M Botta, M Braun, Z Baranyai, ... | 24 | 2017 |
| Methods for identifying and isolating cells expressing a polypeptide AL Gurney, ALL Lazetic, CJ Bond US Patent 8,551,715, 2013 | 16 | 2013 |
| VEGF binding antibodies AL Gurney, AK Sato, CJ Bond US Patent 9,376,488, 2016 | 15 | 2016 |
| Isomeric Co (ii) paraCEST agents as pH responsive MRI probes CJ Bond, R Cineus, AY Nazarenko, JA Spernyak, JR Morrow Dalton Transactions 49 (2), 279-284, 2020 | 14 | 2020 |
| RSPO3 binding agents and uses thereof AL Gurney, CJ Bond US Patent 9,181,333, 2015 | 11 | 2015 |
| VEGF/DLL4 Binding Agents and Uses Thereof AL Gurney, AK Sato, CJ Bond US Patent App. 15/401,543, 2017 | 10 | 2017 |
| Methods for identifying and isolating cells expressing a polypeptide AL Gurney, ALL Lazetic, CJ Bond US Patent 9,023,621, 2015 | 10 | 2015 |
| Polynucleotides encoding VEGF/DLL4 binding agents AL Gurney, AK Sato, CJ Bond US Patent 9,574,009, 2017 | 9 | 2017 |
